These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
31-1168055
|
|
(State of incorporation)
|
|
(I.R.S. Employer Identification No.)
|
|
(
480) 781-5000
|
||
|
(Telephone Number)
|
||
|
16430 North Scottsdale Road, Suite 400, Scottsdale, Arizona 85254
|
||
|
(Address of principal executive office, including zip code)
|
||
|
Large accelerated filer ☒
|
Accelerated filer ☐
|
|
|
|
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
|
|
|
|
|
Emerging growth company ☐
|
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions except share and per share amounts)
|
|
2018
|
|
2017
|
||||
|
Revenues
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Cost of goods sold
|
|
|
|
|
|
|
||
|
Selling and administrative expenses
|
|
|
|
|
|
|
||
|
Research and development expenses
|
|
|
|
|
|
|
||
|
Other operating (income) expense, net
|
|
(
|
)
|
|
(
|
)
|
||
|
Operating income
|
|
|
|
|
|
|
||
|
Interest expense, net
|
|
|
|
|
|
|
||
|
Other non-operating (income) expense, net
|
|
|
|
|
(
|
)
|
||
|
Income from continuing operations before income taxes
|
|
|
|
|
|
|
||
|
Provision for income taxes
|
|
|
|
|
|
|
||
|
Income from continuing operations
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Discontinued operations:
|
|
|
|
|
|
|
||
|
Income before income taxes
|
|
|
|
|
|
|
||
|
Provision for income taxes
|
|
|
|
|
|
|
||
|
Income from discontinued operations
|
|
|
|
|
|
|
||
|
Net income
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Basic earnings per share attributable to common shares:
|
|
|
|
|
|
|
||
|
Income from continuing operations
|
|
$
|
|
|
|
$
|
|
|
|
Income from discontinued operations
|
|
|
|
|
|
|
||
|
Basic earnings per share
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Diluted earnings per share attributable to common shares:
|
|
|
|
|
|
|
||
|
Income from continuing operations
|
|
$
|
|
|
|
$
|
|
|
|
Income from discontinued operations
|
|
|
|
|
|
|
||
|
Diluted earnings per share
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Average shares outstanding (in thousands):
|
|
|
|
|
|
|
||
|
Basic
|
|
|
|
|
|
|
||
|
Diluted
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Dividends declared and paid per share
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Comprehensive income:
|
|
|
|
|
|
|
||
|
Net income
|
|
$
|
|
|
|
$
|
|
|
|
Other comprehensive income (loss)
|
|
|
|
|
|
|
||
|
Foreign currency translation
|
|
|
|
|
|
|
||
|
Accrued post-retirement benefit liability, net of tax
|
|
|
|
|
|
|
||
|
Other, net of tax
|
|
|
|
|
(
|
)
|
||
|
Other comprehensive income
|
|
|
|
|
|
|
||
|
Comprehensive income
|
|
$
|
|
|
|
$
|
|
|
|
(in millions except share and per share amounts)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
ASSETS
|
|
(Unaudited)
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
|
|
|
$
|
|
|
|
Receivables, net of allowance of $6.0 million and $6.5 million, respectively
|
|
|
|
|
|
|
||
|
Inventories
|
|
|
|
|
|
|
||
|
Prepaid expenses
|
|
|
|
|
|
|
||
|
Other current assets
|
|
|
|
|
|
|
||
|
Discontinued operations
|
|
|
|
|
|
|
||
|
Total current assets
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Property, plant, and equipment, net
|
|
|
|
|
|
|
||
|
Goodwill, net
|
|
|
|
|
|
|
||
|
Other intangible assets, net
|
|
|
|
|
|
|
||
|
Other long-term assets
|
|
|
|
|
|
|
||
|
Discontinued operations
|
|
|
|
|
|
|
||
|
Total assets
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
|
|
|
$
|
|
|
|
Accrued expenses
|
|
|
|
|
|
|
||
|
Deferred revenue
|
|
|
|
|
|
|
||
|
Discontinued operations
|
|
|
|
|
|
|
||
|
Total current liabilities
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Long-term liabilities:
|
|
|
|
|
||||
|
Long-term debt
|
|
|
|
|
|
|
||
|
Deferred revenue
|
|
|
|
|
|
|
||
|
Other long-term liabilities
|
|
|
|
|
|
|
||
|
Discontinued operations
|
|
|
|
|
|
|
||
|
Total long-term liabilities
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Shareholders' equity:
|
|
|
|
|
||||
|
Preferred stock, $1 par value per share (5,000,000 shares authorized and unissued)
|
|
|
|
|
|
|
||
|
Common stock, $1 par value per share (200,000,000 shares; 60,759,416 and 61,839,734 shares outstanding, respectively)
|
|
|
|
|
|
|
||
|
Additional paid-in capital
|
|
|
|
|
|
|
||
|
Deferred compensation equity
|
|
|
|
|
|
|
||
|
Treasury shares, at cost (17,713,502 and 16,613,193 shares, respectively)
|
|
(
|
)
|
|
(
|
)
|
||
|
Accumulated other comprehensive loss
|
|
(
|
)
|
|
(
|
)
|
||
|
Retained earnings
|
|
|
|
|
|
|
||
|
Total shareholders' equity
|
|
|
|
|
|
|
||
|
Total liabilities and equity
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions)
|
|
2018
|
|
2017
|
||||
|
Operating activities:
|
|
|
|
|
||||
|
Net income
|
|
$
|
|
|
|
$
|
|
|
|
Reconciliation of net income to net cash provided by operating activities:
|
|
|
|
|
|
|
||
|
Depreciation
|
|
|
|
|
|
|
||
|
Amortization
|
|
|
|
|
|
|
||
|
Stock-based compensation, net of tax benefit
|
|
|
|
|
|
|
||
|
Deferred taxes
|
|
(
|
)
|
|
(
|
)
|
||
|
Gain on sale of discontinued operation, net of tax
|
|
(
|
)
|
|
|
|
||
|
Other operating activities, net
|
|
(
|
)
|
|
|
|
||
|
Changes in assets and liabilities, excluding effects of acquisitions:
|
|
|
|
|
|
|
||
|
Receivables
|
|
(
|
)
|
|
(
|
)
|
||
|
Inventories
|
|
(
|
)
|
|
(
|
)
|
||
|
Prepaid expenses and other assets
|
|
|
|
|
|
|
||
|
Accounts payable
|
|
|
|
|
|
|
||
|
Accrued expenses
|
|
(
|
)
|
|
(
|
)
|
||
|
Deferred revenues
|
|
|
|
|
|
|
||
|
Other long-term liabilities
|
|
|
|
|
(
|
)
|
||
|
Net cash provided by operating activities
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Investing activities:
|
|
|
|
|
||||
|
Proceeds from sale of discontinued operation
|
|
|
|
|
|
|
||
|
Capital expenditures
|
|
(
|
)
|
|
(
|
)
|
||
|
Acquisitions, net of cash acquired
|
|
(
|
)
|
|
(
|
)
|
||
|
Other investing activities, net
|
|
|
|
|
|
|
||
|
Net cash provided by (used in) investing activities
|
|
|
|
|
(
|
)
|
||
|
|
|
|
|
|
||||
|
Financing activities:
|
|
|
|
|
||||
|
Proceeds from revolving credit facility
|
|
|
|
|
|
|
||
|
Repayments of revolving credit facility
|
|
|
|
|
(
|
)
|
||
|
Repurchases of common stock
|
|
(
|
)
|
|
|
|
||
|
Dividends paid
|
|
(
|
)
|
|
(
|
)
|
||
|
Withholding tax paid related to stock-based compensation
|
|
(
|
)
|
|
(
|
)
|
||
|
Proceeds from exercise of stock options
|
|
|
|
|
|
|
||
|
Net cash used in financing activities
|
|
(
|
)
|
|
(
|
)
|
||
|
|
|
|
|
|
||||
|
Effect of foreign currency exchange rate changes on cash and cash equivalents
|
|
|
|
|
|
|
||
|
Change in cash and cash equivalents
|
|
|
|
|
(
|
)
|
||
|
Less: Change in cash and cash equivalents of discontinued operations
|
|
(
|
)
|
|
(
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Deferred Compensation Equity
|
|
Accumulated Other Comprehensive Income (loss)
|
|
Retained Earnings
|
|
Shares in Treasury
|
|
Total Shareholders' Equity
|
||||||||||||||||||||
|
(in millions, except per share amounts)
|
|
Shares
|
|
Amount
|
|
|
|
|
|
Shares
|
|
Cost
|
|
|||||||||||||||||||||
|
Balance as of December 31, 2016
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Other comprehensive loss, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Cash dividends - $0.35 per share
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||||
|
Issuances and deferrals, net for stock based compensation
(1)
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|||||||
|
Balance as of March 31, 2017
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Balance as of December 31, 2017
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Adoption of accounting standards
(2)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Other comprehensive income, net of tax
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Cash dividends - $0.37 per share
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||||
|
Repurchases of common stock
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||
|
Issuances and deferrals, net for stock based compensation
(1)
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||||
|
Balance as of March 31, 2018
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
(1)
|
|
|
(2)
|
|
|
|
|
Three Months Ended March 31, 2018
|
||||||||||
|
(in millions)
|
|
As Reported
|
|
Balances Without Adoption of
ASC 606
|
|
Effect of Change Higher/(Lower)
|
||||||
|
Condensed Consolidated Statement of Income
|
|
|
|
|
|
|
||||||
|
Revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Cost of goods sold
|
|
|
|
|
|
|
|
|
|
|||
|
Operating income
|
|
|
|
|
|
|
|
|
|
|||
|
Provision for income taxes
|
|
|
|
|
|
|
|
|
|
|||
|
Income from continuing operations
|
|
|
|
|
|
|
|
|
|
|||
|
Net income
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
March 31, 2018
|
||||||||||
|
(in millions)
|
|
As Reported
|
|
Balances Without Adoption of
ASC 606
|
|
Effect of Change Higher/(Lower)
|
||||||
|
Condensed Consolidated Balance Sheet
|
|
|
|
|
|
|
||||||
|
Receivables
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Inventories
|
|
|
|
|
|
|
|
(
|
)
|
|||
|
Other current assets
|
|
|
|
|
|
|
|
|
|
|||
|
Accrued expenses
|
|
|
|
|
|
|
|
|
|
|||
|
Other long-term liabilities
|
|
|
|
|
|
|
|
|
|
|||
|
Retained earnings
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
Three Months Ended March 31,
|
||||||||||||||
|
|
|
2018
|
|
2017
|
||||||||||||
|
(in millions)
|
|
Revenues
|
|
Operating Income
|
|
Revenues
|
|
Operating Income
|
||||||||
|
Carlisle Construction Materials
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Carlisle Interconnect Technologies
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Carlisle Fluid Technologies
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Carlisle Brake & Friction
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Segment total
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Corporate and unallocated
(1)
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
||||
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
(1)
|
|
|
|
|
Unaudited Pro Forma
|
||
|
|
|
Three Months Ended
March 31, 2017
|
||
|
(in millions)
|
|
|||
|
Revenues
|
|
$
|
|
|
|
Income from continuing operations
|
|
|
|
|
|
|
|
Preliminary Allocation
|
|
Measurement Period Adjustments
|
|
Revised Preliminary Allocation
|
||||||
|
(in millions)
|
|
As of 11/1/2017
|
|
|
As of 3/31/2018
|
|||||||
|
Total cash consideration transferred
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Recognized amounts of identifiable assets acquired and liabilities assumed:
|
|
|
|
|
|
|
||||||
|
Cash and cash equivalents
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Receivables, net
|
|
|
|
|
|
|
|
|
|
|||
|
Inventories
|
|
|
|
|
(
|
)
|
|
|
|
|||
|
Prepaid expenses and other current assets
|
|
|
|
|
|
|
|
|
|
|||
|
Property, plant and equipment
|
|
|
|
|
|
|
|
|
|
|||
|
Definite-lived intangible assets
|
|
|
|
|
|
|
|
|
|
|||
|
Other long-term assets
|
|
|
|
|
|
|
|
|
|
|||
|
Accounts payable
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
Income tax payable
|
|
|
|
|
|
|
|
|
|
|||
|
Accrued expenses
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
Other long-term liabilities
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
Deferred income taxes
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||
|
Total identifiable net assets
|
|
|
|
|
(
|
)
|
|
|
|
|||
|
Goodwill
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
|||||
|
Revenues
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Cost of goods sold
|
|
|
|
|
|
|
||
|
Other operating expenses, net
|
|
|
|
|
|
|
||
|
Operating income
|
|
|
|
|
|
|
||
|
Other non-operating (income) expense, net
|
|
|
|
|
|
|
||
|
Income from discontinued operations before income taxes
|
|
|
|
|
|
|
||
|
Gain on sale of discontinued operations
|
|
|
|
|
|
|
||
|
Provision for income taxes
|
|
|
|
|
|
|
||
|
Income from discontinued operations
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
December 31, 2017
|
||
|
ASSETS
|
|
|
||
|
Cash and cash equivalents
|
|
$
|
|
|
|
Receivables, net
|
|
|
|
|
|
Inventories
|
|
|
|
|
|
Prepaid other current assets
|
|
|
|
|
|
Total current assets
|
|
$
|
|
|
|
|
|
|
||
|
Property, plant, and equipment, net
|
|
$
|
|
|
|
Goodwill, net
|
|
|
|
|
|
Other intangible assets, net
|
|
|
|
|
|
Other long-term assets
|
|
|
|
|
|
Total long-term assets
|
|
$
|
|
|
|
|
|
|
||
|
LIABILITIES
|
|
|
||
|
Accounts payable
|
|
$
|
|
|
|
Accrued expenses
|
|
|
|
|
|
Total current liabilities
|
|
$
|
|
|
|
|
|
|
||
|
Other long-term liabilities
|
|
$
|
|
|
|
Total long-term liabilities
|
|
$
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
|||||
|
Net cash provided by operating activities
|
|
$
|
|
|
|
$
|
|
|
|
Net cash used in investing activities
|
|
(
|
)
|
|
(
|
)
|
||
|
Net cash provided by financing activities
(1)
|
|
|
|
|
|
|
||
|
Change in cash and cash equivalents from discontinued operations
|
|
$
|
|
|
|
$
|
|
|
|
(1)
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions except share and per share amounts)
|
|
2018
|
|
2017
|
||||
|
Income from continuing operations
|
|
$
|
|
|
|
$
|
|
|
|
Less: dividends declared on common stock outstanding, restricted shares and restricted share units
|
|
(
|
)
|
|
(
|
)
|
||
|
Undistributed earnings
|
|
|
|
|
|
|
||
|
Percent allocated to common shareholders
(1)
|
|
|
%
|
|
|
%
|
||
|
|
|
|
|
|
|
|
||
|
Add: dividends declared on common stock
|
|
|
|
|
|
|
||
|
Income from continuing operations attributable to common shares
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
Shares (in thousands):
|
|
|
|
|
||||
|
Weighted-average common shares outstanding
|
|
|
|
|
|
|
||
|
Effect of dilutive securities:
|
|
|
|
|
||||
|
Performance awards
|
|
|
|
|
|
|
||
|
Stock options
|
|
|
|
|
|
|
||
|
Adjusted weighted-average common shares outstanding and assumed conversion
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
Per share income from continuing operations attributable to common shares:
|
|
|
|
|
||||
|
Basic
|
|
$
|
|
|
|
$
|
|
|
|
Diluted
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
||||
|
(1)
Basic weighted-average common shares outstanding
|
|
|
|
|
|
|
||
|
Basic weighted-average common shares outstanding, unvested restricted shares expected to vest and restricted share units
|
|
|
|
|
|
|
||
|
Percent allocated to common shareholders
|
|
|
%
|
|
|
%
|
||
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions except share amounts presented in thousands)
|
|
2018
|
|
2017
|
||||
|
Income from discontinued operations attributable to common shareholders for basic and diluted earnings per share
|
|
$
|
|
|
|
$
|
|
|
|
Net income attributable to common shareholders for basic and diluted earnings per share
|
|
|
|
|
|
|
||
|
Anti-dilutive stock options excluded from EPS calculation
(1)
|
|
|
|
|
|
|
||
|
(1)
|
|
|
|
|
Three Months Ended March 31, 2018
|
||||||||||||||||||
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||||
|
Products transferred at a point in time
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Products and services transferred over time
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Three Months Ended March 31, 2017
|
||||||||||||||||||
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||||
|
Products transferred at a point in time
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Products and services transferred over time
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
Remainder of 2018
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
||||||||||||||
|
Extended service warranties
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
2018
|
|
2017
|
||||
|
Balance as of January 1
|
|
$
|
|
|
|
$
|
|
|
|
Revenue recognized
|
|
(
|
)
|
|
(
|
)
|
||
|
Revenue deferred
|
|
|
|
|
|
|
||
|
Acquired liabilities
|
|
|
|
|
|
|
||
|
Balance as of March 31
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
2018
|
||
|
Balance as of January 1
|
|
$
|
|
|
|
Adoption of ASC 606
|
|
|
|
|
|
Revenue recognized and unbilled
|
|
|
|
|
|
Revenue billed
|
|
(
|
)
|
|
|
Balance as of March 31
|
|
$
|
|
|
|
|
|
Three Months Ended March 31, 2018
|
||||||||||||||||||
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||||
|
General construction
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Aerospace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Heavy equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Transportation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Medical
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
General industrial and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Three Months Ended March 31, 2017
|
||||||||||||||||||
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||||
|
General construction
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Aerospace
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Heavy equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Transportation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Medical
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
General industrial and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Three Months Ended March 31, 2018
|
||||||||||||||||||
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||||
|
United States
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Europe
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Asia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Mexico and Latin America
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Middle East and Africa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total international
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
Three Months Ended March 31, 2017
|
||||||||||||||||||
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||||
|
United States
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Europe
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Asia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Mexico and Latin America
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Middle East and Africa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total international
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
•
|
Non-cash accelerated depreciation of long-lived assets at the Oklahoma facility, which is primarily property, plant and equipment that will not be transferred to Ohio (between
$
|
|
•
|
Costs to relocate and install equipment (between
$
|
|
•
|
Employee retention and termination benefits (approximately
$
|
|
•
|
Other associated costs related to the closure of the facility and internal administration of the project (between
$
|
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
|||||
|
Accelerated depreciation
|
|
$
|
|
|
|
$
|
|
|
|
Employee severance and benefit arrangements
|
|
|
|
|
|
|
||
|
Relocation costs
|
|
|
|
|
|
|
||
|
Other restructuring costs
|
|
|
|
|
|
|
||
|
Total exit and disposal costs
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
|||||
|
Carlisle Brake & Friction
|
|
$
|
|
|
|
$
|
|
|
|
Carlisle Interconnect Technologies
|
|
|
|
|
|
|
||
|
Carlisle Fluid Technologies
|
|
|
|
|
|
|
||
|
Corporate
|
|
|
|
|
|
|
||
|
Total exit and disposal costs
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||
|
|
2018
|
|
2017
|
|||||
|
Cost of goods sold
|
|
$
|
|
|
|
$
|
|
|
|
Selling and administrative expenses
|
|
|
|
|
|
|
||
|
Other operating (income) expense, net
|
|
|
|
|
|
|
||
|
Research and development expenses
|
|
|
|
|
|
|
||
|
Total exit and disposal costs
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
CIT
|
|
CFT
|
|
CBF
|
|
Total
|
||||||||
|
Balance as of January 1, 2018
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Charges
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cash payments
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Other adjustments and non-cash settlements
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||
|
Balance as of March 31, 2018
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Raw Materials
|
|
$
|
|
|
|
$
|
|
|
|
Work-in-process
|
|
|
|
|
|
|
||
|
Finished goods
|
|
|
|
|
|
|
||
|
Reserves
|
|
(
|
)
|
|
(
|
)
|
||
|
Inventories
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
CCM
|
|
CIT
|
|
CFT
|
|
CBF
(1)
|
|
Total
|
||||||||||
|
Balance as of December 31, 2017
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Goodwill acquired during year
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Measurement period adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Currency translation and other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Balance as of March 31, 2018
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
(1)
|
CBF goodwill balance as of
December 31, 2017
, is presented net of accumulated impairment losses of
$
|
|
(2)
|
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||||||||||
|
(in millions)
|
|
Acquired
Cost
|
|
Accumulated
Amortization
|
|
Net Book Value
|
|
Acquired
Cost
|
|
Accumulated
Amortization
|
|
Net Book Value
|
||||||||||||
|
Assets subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Customer relationships
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Technology and intellectual property
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
|
Trade names and other
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||
|
Assets not subject to amortization:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Trade names
|
|
|
|
|
—
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||
|
Other intangible assets, net
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
(in millions)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Carlisle Construction Materials
|
|
$
|
|
|
|
$
|
|
|
|
Carlisle Interconnect Technologies
|
|
|
|
|
|
|
||
|
Carlisle Fluid Technologies
|
|
|
|
|
|
|
||
|
Carlisle Brake & Friction
|
|
|
|
|
|
|
||
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
(in millions)
|
|
|
|
|
|
Fair Value
(1)
|
||||||||||
|
|
March 31, 2018
|
|
December 31, 2017
|
|
March 31, 2018
|
|
December 31, 2017
|
|||||||||
|
3.75% Notes due 2027
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
3.5% Notes due 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
3.75% Notes due 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
5.125% Notes due 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Unamortized discount, debt issuance costs, and other
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
||||||
|
Total long term-debt
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
||||
|
(1)
|
|
|
(in millions)
|
|
2018
|
|
2017
|
||||
|
Service cost
|
|
$
|
|
|
|
$
|
|
|
|
Interest cost
|
|
|
|
|
|
|
||
|
Expected return on plan assets
|
|
(
|
)
|
|
(
|
)
|
||
|
Amortization of unrecognized loss
(1)
|
|
|
|
|
|
|
||
|
Net periodic benefit cost
|
|
$
|
|
|
|
$
|
|
|
|
(1)
|
|
|
(in millions)
|
|
2018
|
|
2017
|
||||
|
Balance as of January 1
|
|
$
|
|
|
|
$
|
|
|
|
Current year provision
|
|
|
|
|
|
|
||
|
Current year claims
|
|
(
|
)
|
|
(
|
)
|
||
|
Currency translation
|
|
|
|
|
|
|
||
|
Balance as of March 31
|
|
$
|
|
|
|
$
|
|
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||
|
(in millions)
|
|
Fair Value
(1)
|
|
Notional Value
|
|
Fair Value
(1)
|
|
Notional Value
|
||||||||
|
Designated hedges
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Non-designated hedges
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
(1)
|
|
|
(in millions)
|
|
2018
|
|
2017
|
||||
|
Balance as of January 1
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Other comprehensive income before reclassifications
|
|
|
|
|
|
|
||
|
Amounts reclassified from accumulated other comprehensive loss
|
|
(
|
)
|
|
(
|
)
|
||
|
Other comprehensive income (loss)
|
|
|
|
|
(
|
)
|
||
|
Balance as of March 31
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions, except per share amounts)
|
|
2018
|
|
2017
|
||||
|
Revenues
|
|
$
|
984.7
|
|
|
$
|
774.0
|
|
|
Operating income
|
|
$
|
94.7
|
|
|
$
|
89.5
|
|
|
Operating margin percentage
|
|
9.6
|
%
|
|
11.6
|
%
|
||
|
Income from continuing operations
|
|
$
|
57.9
|
|
|
$
|
57.9
|
|
|
Income from discontinued operations
|
|
$
|
251.7
|
|
|
$
|
3.9
|
|
|
Diluted earnings per share attributable to common shares:
|
|
|
|
|
||||
|
Income from continuing operations
|
|
$
|
0.92
|
|
|
$
|
0.88
|
|
|
Income from discontinued operations
|
|
$
|
4.02
|
|
|
$
|
0.06
|
|
|
|
|
|
|
|
||||
|
Items affecting comparability:
(1)
|
|
|
|
|
||||
|
Impact to operating income
|
|
$
|
4.4
|
|
|
$
|
7.0
|
|
|
Impact to income from continuing operations
|
|
$
|
3.4
|
|
|
$
|
4.9
|
|
|
Impact on diluted EPS from continuing operations
|
|
$
|
0.05
|
|
|
$
|
0.08
|
|
|
(1)
|
Items affecting comparability primarily include acquisition related costs, exit and disposal costs, facility rationalization costs and gains from divestitures. Tax effect is based on the rate of the jurisdiction where the expense is deductible. Refer to
Items Affecting Comparability
in this MD&A for further discussion.
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|
Acquisition Effect
|
|
Price / Volume Effect
|
|
Exchange Rate Effect
|
||||||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|
|
|
||||||||||||||
|
Revenues
|
|
$
|
984.7
|
|
|
$
|
774.0
|
|
|
$
|
210.7
|
|
|
27.2
|
%
|
|
15.5
|
%
|
|
10.2
|
%
|
|
1.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
||||||||
|
Gross margin
|
|
$
|
249.4
|
|
|
$
|
226.1
|
|
|
$
|
23.3
|
|
|
10.3
|
%
|
|
Gross margin percentage
|
|
25.3
|
%
|
|
29.2
|
%
|
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
$
|
26.2
|
|
|
$
|
19.2
|
|
|
|
|
|
|||
|
(in millions)
|
|
Three Months Ended March 31,
|
|||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
||||||||
|
Selling and administrative expenses
|
|
$
|
148.6
|
|
|
$
|
124.9
|
|
|
$
|
23.7
|
|
|
19.0
|
%
|
|
As a percentage of revenues
|
|
15.1
|
%
|
|
16.1
|
%
|
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
$
|
19.3
|
|
|
$
|
14.0
|
|
|
|
|
|
|||
|
(in millions)
|
|
Three Months Ended March 31,
|
|||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
||||||||
|
Research and development expenses
|
|
$
|
13.9
|
|
|
$
|
12.0
|
|
|
$
|
1.9
|
|
|
15.8
|
%
|
|
As a percentage of revenues
|
|
1.4
|
%
|
|
1.6
|
%
|
|
|
|
|
|||||
|
Depreciation and amortization
|
|
$
|
0.4
|
|
|
$
|
0.3
|
|
|
|
|
|
|||
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||
|
Other operating (income) expense, net
|
|
$
|
(7.8
|
)
|
|
$
|
(0.3
|
)
|
|
$
|
(7.5
|
)
|
|
NM
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
||||||||
|
Operating income
|
|
$
|
94.7
|
|
|
$
|
89.5
|
|
|
$
|
5.2
|
|
|
5.8
|
%
|
|
Operating margin percentage
|
|
9.6
|
%
|
|
11.6
|
%
|
|
|
|
|
|||||
|
(in millions)
|
|
Three Months Ended March 31,
|
|||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
||||||||
|
Interest expense
|
|
$
|
15.4
|
|
|
$
|
6.8
|
|
|
|
|
|
|||
|
Interest income
|
|
(0.9
|
)
|
|
(0.2
|
)
|
|
|
|
|
|||||
|
Interest expense, net
|
|
$
|
14.5
|
|
|
$
|
6.6
|
|
|
$
|
7.9
|
|
|
119.7
|
%
|
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||
|
Other non-operating (income) expense, net
|
|
$
|
1.9
|
|
|
$
|
(1.4
|
)
|
|
$
|
3.3
|
|
|
NM
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
||||||||
|
Provision for income taxes
|
|
$
|
20.4
|
|
|
$
|
26.4
|
|
|
$
|
(6.0
|
)
|
|
(22.7
|
)%
|
|
Effective tax rate
|
|
26.1
|
%
|
|
31.3
|
%
|
|
|
|
|
|||||
|
(in millions)
|
|
Three Months Ended March 31,
|
||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||
|
Income from discontinued operations before taxes
|
|
$
|
299.0
|
|
|
$
|
6.2
|
|
|
|
|
|
||
|
Provision for income taxes
|
|
47.3
|
|
|
2.3
|
|
|
|
|
|
||||
|
Income from discontinued operations
|
|
$
|
251.7
|
|
|
$
|
3.9
|
|
|
$
|
247.8
|
|
|
NM
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|
Acquisition Effect
|
|
Price / Volume Effect
|
|
Exchange Rate Effect
|
||||||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||||||||||||
|
Revenues
|
|
$
|
598.6
|
|
|
$
|
446.1
|
|
|
$
|
152.5
|
|
|
34.2
|
%
|
|
26.9
|
%
|
|
6.3
|
%
|
|
1.0
|
%
|
|
Operating income
|
|
$
|
75.8
|
|
|
$
|
80.7
|
|
|
$
|
(4.9
|
)
|
|
(6.1
|
)%
|
|
|
|
|
|
|
|||
|
Operating margin percentage
|
|
12.7
|
%
|
|
18.1
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Depreciation and amortization
|
|
$
|
19.1
|
|
|
$
|
8.7
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Items affecting comparability
(1)
|
|
$
|
(1.8
|
)
|
|
$
|
0.6
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
(1)
|
Items affecting comparability include gains from divestitures of
$(1.8) million
in
first quarter of 2018
, and acquisition related costs of
$0.6 million
in first quarter of 2017, refer to
Items Affecting Comparability
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|
Acquisition Effect
|
|
Price / Volume Effect
|
|
Exchange Rate Effect
|
||||||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||||||||||||
|
Revenues
|
|
$
|
224.3
|
|
|
$
|
194.2
|
|
|
$
|
30.1
|
|
|
15.5
|
%
|
|
—
|
%
|
|
15.3
|
%
|
|
0.2
|
%
|
|
Operating income
|
|
$
|
27.2
|
|
|
$
|
21.5
|
|
|
$
|
5.7
|
|
|
26.5
|
%
|
|
|
|
|
|
|
|
||
|
Operating margin percentage
|
|
12.1
|
%
|
|
11.1
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Depreciation and amortization
|
|
$
|
14.6
|
|
|
$
|
13.4
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Items affecting comparability
(1)
|
|
$
|
2.6
|
|
|
$
|
4.3
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
(1)
|
Items affecting comparability include exit and disposal and facility rationalization costs (
$2.6 million
in
first quarter of 2018
and
$4.3 million
in first quarter of
2017
), refer to
Items Affecting Comparability
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|
Acquisition Effect
|
|
Price / Volume Effect
|
|
Exchange Rate Effect
|
||||||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||||||||||||
|
Revenues
|
|
$
|
63.5
|
|
|
$
|
60.5
|
|
|
$
|
3.0
|
|
|
5.0
|
%
|
|
—
|
%
|
|
(0.1
|
)%
|
|
5.1
|
%
|
|
Operating income
|
|
$
|
5.7
|
|
|
$
|
4.9
|
|
|
$
|
0.8
|
|
|
16.3
|
%
|
|
|
|
|
|
|
|||
|
Operating margin percentage
|
|
9.0
|
%
|
|
8.1
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Depreciation and amortization
|
|
$
|
5.4
|
|
|
$
|
5.4
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Items affecting comparability
(1)
|
|
$
|
0.5
|
|
|
$
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
(1)
|
Items affecting comparability include exit and disposal and facility rationalization costs (
$0.7 million
in
first quarter of 2018
and
$0.5 million
in first quarter of 2017) and gains from divestitures (
$(0.2) million
in
first quarter of 2018
), refer to
Items Affecting Comparability
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
Three Months Ended March 31,
|
|
Acquisition Effect
|
|
Price / Volume Effect
|
|
Exchange Rate Effect
|
||||||||||||||||
|
|
2018
|
|
2017
|
|
Change $
|
|
Change %
|
|||||||||||||||||
|
Revenues
|
|
$
|
98.3
|
|
|
$
|
73.2
|
|
|
$
|
25.1
|
|
|
34.3
|
%
|
|
—
|
%
|
|
28.5
|
%
|
|
5.8
|
%
|
|
Operating income
|
|
$
|
4.5
|
|
|
$
|
1.2
|
|
|
$
|
3.3
|
|
|
275.0
|
%
|
|
|
|
|
|
|
|||
|
Operating margin percentage
|
|
4.6
|
%
|
|
1.6
|
%
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Depreciation and amortization
|
|
$
|
6.1
|
|
|
$
|
5.3
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Items affecting comparability
(1)
|
|
$
|
2.0
|
|
|
$
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
(1)
|
Items affecting comparability and include exit and disposal and facility rationalization costs (
$2.0 million
in the
first quarter of 2018
and
$0.3 million
in first quarter of 2017), refer to
Items Affecting Comparability
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
March 31, 2018
|
|
December 31, 2017
|
||||
|
Europe
|
|
$
|
33.2
|
|
|
$
|
38.1
|
|
|
China
|
|
28.7
|
|
|
17.6
|
|
||
|
Asia Pacific region (excluding China)
|
|
10.9
|
|
|
21.0
|
|
||
|
Other international regions
|
|
22.8
|
|
|
21.7
|
|
||
|
Non-U.S. subsidiaries cash and cash equivalents
|
|
95.6
|
|
|
98.4
|
|
||
|
U.S. subsidiaries cash and cash equivalents
|
|
883.5
|
|
|
279.9
|
|
||
|
Cash and cash equivalents
|
|
$
|
979.1
|
|
|
$
|
378.3
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
(in millions)
|
|
2018
|
|
2017
|
||||
|
Net cash provided by operating activities
|
|
$
|
33.2
|
|
|
$
|
31.9
|
|
|
Net cash provided by (used in) investing activities
|
|
715.0
|
|
|
(256.2
|
)
|
||
|
Net cash used in financing activities
|
|
(148.0
|
)
|
|
(28.1
|
)
|
||
|
Effect of foreign currency exchange rate changes on cash
|
|
1.9
|
|
|
1.1
|
|
||
|
Change in cash and cash equivalents
|
|
$
|
602.1
|
|
|
$
|
(251.3
|
)
|
|
(in millions, except per share amounts)
|
|
Three Months Ended March 31, 2018
|
|
Three Months Ended March 31, 2017
|
||||||||||||||||||||
|
|
Impact to Operating Income
|
|
Impact to Income from Continuing Operations
|
|
Impact to Diluted EPS from Continuing Operations
|
|
Impact to Operating Income
|
|
Impact to Income from Continuing Operations
|
|
Impact to Diluted EPS from Continuing Operations
|
|||||||||||||
|
Exit and disposal costs
|
|
3.1
|
|
|
2.4
|
|
|
0.04
|
|
|
3.2
|
|
|
2.2
|
|
|
0.03
|
|
||||||
|
Other facility rationalization costs
|
|
2.2
|
|
|
1.7
|
|
|
0.02
|
|
|
2.0
|
|
|
1.5
|
|
|
0.03
|
|
||||||
|
Acquisition related costs:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Inventory step-up amortization
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.5
|
|
|
0.4
|
|
|
0.01
|
|
||||||
|
Other acquisition costs
|
|
1.1
|
|
|
0.8
|
|
|
0.01
|
|
|
1.3
|
|
|
0.8
|
|
|
0.01
|
|
||||||
|
(Gains) losses from divestitures
|
|
(2.0
|
)
|
|
(1.5
|
)
|
|
(0.02
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Total items affecting comparability
|
|
$
|
4.4
|
|
|
$
|
3.4
|
|
|
$
|
0.05
|
|
|
$
|
7.0
|
|
|
$
|
4.9
|
|
|
$
|
0.08
|
|
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid Per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
(1)
|
|||||
|
January 2018
|
|
285,126
|
|
|
$
|
116.00
|
|
|
234,974
|
|
|
1,881,177
|
|
|
February 2018
|
|
392,448
|
|
|
106.85
|
|
|
391,000
|
|
|
6,490,177
|
|
|
|
March 2018
|
|
565,029
|
|
|
104.94
|
|
|
561,869
|
|
|
5,928,308
|
|
|
|
Total
|
|
1,242,603
|
|
|
|
|
1,187,843
|
|
|
|
|||
|
(1)
|
Represents the number of shares that can be repurchased under the Company’s stock repurchase program. On February 6, 2018, the Board approved an increase in the Company's stock repurchase for up to 13.7 million shares.
|
|
Exhibit
Number
|
|
|
|
Filed with this Form 10-Q
|
|
Incorporated by Reference
|
||||
|
|
Exhibit Title
|
|
|
Form
|
|
File No.
|
|
Date Filed
|
||
|
2.1
*
|
|
Stock Purchase Agreement, dated as of January 31, 2018, by and among Carlisle, LLC, Carlisle Foodservice Products, Incorporated, CFSP Acquisition Corp. and Carlisle Companies Incorporated.
|
|
|
|
8-K
|
|
001-9278
|
|
2/2/2018
|
|
|
Restated Certificate of Incorporation of the Company.
|
|
|
|
10-Q
|
|
001-9278
|
|
10/21/2015
|
|
|
|
Amended and Restated Bylaws of the Company.
|
|
|
|
8-K
|
|
001-9278
|
|
12/14/2015
|
|
|
4.1
P
|
|
Form of Trust Indenture between the Company and Fleet National Bank.
|
|
|
|
S-3
|
|
333-16785
|
|
11/26/1996
|
|
|
First Supplemental Indenture, dated as of August 18, 2006, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.
|
|
|
|
8-K
|
|
001-9278
|
|
8/18/2006
|
|
|
|
Second Supplemental Indenture, dated as of December 9, 2010, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.
|
|
|
|
8-K
|
|
001-9278
|
|
12/10/2010
|
|
|
|
Third Supplemental Indenture, dated as of November 20, 2012, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.
|
|
|
|
8-K
|
|
001-9278
|
|
11/20/2012
|
|
|
|
Form of 3.500% Notes due 2024.
|
|
|
|
8-K
|
|
001-9278
|
|
11/16/2017
|
|
|
|
Form of 3.750% Notes due 2027.
|
|
|
|
8-K
|
|
001-9278
|
|
11/16/2017
|
|
|
|
Form of Trademark License Agreement between Carlisle Intangible Company, LLC and Carlisle FoodService Products, Incorporated.
|
|
|
|
8-K
|
|
001-9278
|
|
2/2/2018
|
|
|
|
Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
X
|
|
|
|
|
|
|
|
|
|
Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).
|
|
X
|
|
|
|
|
|
|
|
|
|
Section 1350 Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
X
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
X
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
X
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
X
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
X
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
X
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
X
|
|
|
|
|
|
|
|
|
Carlisle Companies Incorporated
|
|
|
|
|
|
|
April 27, 2018
|
|
|
|
|
By: /s/ Robert M. Roche
|
|
|
|
Name: Robert M. Roche
|
|
|
|
Title: Vice President and Chief Financial Officer
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|